The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of...
This indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, aims to provide preclinical models of infectious diseases to support the development and evaluation of medical countermeasures. The single award contract, valued at up to $146.3 million, has a 7-year ordering period and covers three task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of Infectious Diseases Task Area C...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3M Indefinite Delivery Contract to Trustees of Tufts College, doing business as Tufts University School of Medicine, to provide pre-clinical research and development services related to infectious disease models. The contract has a 7-year ordering period and aims to support NIAID's Division of Microbiology and Infectious Diseases in developing and refining animal and animal replacement models for...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031. The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded this $146.3 million single award Indefinite Delivery Contract to the University of Louisville to provide preclinical models of infectious diseases over a 7-year ordering period ending in 2031. The contract supports NIAID's mission to facilitate research on understanding, treating, and preventing infectious diseases by enabling the development and refinement of small animal, non-human primate, and non-traditional animal...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded multiple indefinite delivery/indefinite quantity contracts to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. Services will be conducted under seven task areas including in vitro testing, synthesis of therapeutic agents, small animal models for...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, has awarded a single-award Indefinite Delivery Contract (IDC) valued at $146.3 million to the University of Cincinnati. The contract, titled "Pre-Clinical Models of Infectious Diseases - Task Area A," has an ordering period through July 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop, refine, and employ...
The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a single-award Indefinite Delivery Contract valued at $146.3 million to the American Type Culture Collection (ATCC), a nonprofit organization, to provide a range of preclinical infectious disease models and specialized reagents. The contract aims to support the development, refinement, and utilization of animal and animal replacement models to evaluate candidate medical...
This Indefinite Delivery Contract (IDC), awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, is focused on providing pre-clinical models of infectious diseases. The $146.3 million single-award contract was granted to The Regents of the University of California, San Francisco (UCSF), a U.S. state government and educational institution, for a period of performance from July 2024 through April 2030. The contract aims to develop and refine animal and...